Moderna President Says All Vaccines’ Efficacy May Struggle Against Omicron

Moderna President Says All Vaccines’ Efficacy May Struggle Against Omicron
Three vials of the "Moderna COVID-19 Vaccine" at a new COVID-19 vaccination center at the "Velodrom" (velodrome-stadium) in Berlin, Germany, on Feb. 17, 2021. Michael Sohn/Pool/Getty Images
Lorenz Duchamps
Updated:

Moderna President Stephen Hoge said there is a risk that existing COVID-19 shots may struggle in their effectiveness against the Omicron variant, though it’s too early to say by how much.

Hoge’s comments follow those of Moderna’s Chief Executive Officer Stéphane Bancel, who said last week that he predicts current vaccines will be far less effective against the latest CCP (Chinese Communist Party) virus variant due to the high number of mutations on the spike protein.
Lorenz Duchamps
Lorenz Duchamps
Author
Lorenz Duchamps is a news writer for NTD, The Epoch Times’ sister media, focusing primarily on the United States, world, and entertainment news.
Related Topics